|
1
|
Park SY, Yook CS, Nohara T, Mizutani T and
Tanaka T: Random amplified polymorphic DNA analysis of genetic
relationships among Acanthopanax species. Arch Pharm Res.
27:1270–1274. 2004. View Article : Google Scholar
|
|
2
|
Park SY: Studies on RAPD analysis and
triterpenoidal constituents of Acanthopanax species. Kumamoto
University Press; 3. pp. 1–3. 2002
|
|
3
|
Phuong NT, Lee KA, Jeong SJ, Fu CX, Choi
JK, Kim YH and Kang JS: Capillary electrophoretic method for the
determination of diterpenoid isomers in Acanthopanax species. J
Pharm Biomed Anal. 40:56–61. 2006. View Article : Google Scholar
|
|
4
|
Kang JS, Linh PT, Cai XF, Kim HS, Lee JJ
and Kim YH: Quantitative determination of eleutheroside B and E
from Acanthopanax species by high performance liquid
chromatography. Arch Pharm Res. 24:407–411. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Z, Kim JH, Liu XQ, Lee KT and Yook CS:
Anticancer effects in vitro and chemical compositions of extracts
of Acanthopanax henryi. Journal of Acupuncture and Herbs. 1:49–54.
2014.
|
|
6
|
Li Z, Li XJ, Kwon OX, Wang X, Zou QP, Liu
XQ and Lee HK: Chemical constituents from leaves of Acanthopanax
henryi (II). Nat Prod Sci. 21:196–204. 2015.
|
|
7
|
Lumeng CN and Saltiel AR: Inflammatory
links between obesity and metabolic disease. J Clin Invest.
121:2111–2117. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balija TM and Lowry SF: Lipopolysaccharide
and sepsis-associated myocardial dysfunction. Cur Opin Infect Dis.
24:248–253. 2011. View Article : Google Scholar
|
|
9
|
Peri F, Piazza M, Calabrese V, Damore G
and Cighetti R: Exploring the LPS/TLR-4 signal pathway with small
molecules. Biochem Soc Trans. 38:1390–1395. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nathan C: Nitric oxide as a secretory
product of mammalian cells. FASEB J. 6:3051–3064. 1992.PubMed/NCBI
|
|
11
|
Zhao L, Weber PA, Smith JR, Comerford ML
and Elliott GT: Role of inducible nitric oxide synthase in
pharmacological 'preconditioningʼ with monophosphoryl lipid A. J
Mol Cell Cardiol. 29:1567–1576. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hawkey CJ: COX-2 inhibitors. Lancet.
353:307–314. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mclnturff JE, Modlin RL and Kim J: The
role of toll-like receptors in the pathogenesis and treatment of
dermatological disease. J Invest Dermatol. 125:1–8. 2005.
View Article : Google Scholar
|
|
14
|
Rock FL, Hardiman G, Timans JC, Kastelein
RA and Bazan JF: A family of human receptors structurally related
to Drosophila Toll. Proc Natl Acad Sci USA. 95:588–593. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Medzhitov R, Preston-Hurlburt P and
Janeway CA Jr: A human homologue of the Drosophila Toll protein
signals activation of adaptive immunity. Nature. 388:394–397. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Zhou J, Chen X, Fortenbery N,
Eksioglu EA, Wei S and Dong J: Attenuation of LPS-induced
inflammation by ICT, a derivate of icariin, bia inhibition of the
CD14/TLR-4 signaling pathway in human monocytes. Int
Immunopharmacol. 12:74–79. 2012. View Article : Google Scholar
|
|
17
|
Chen CC and Wang JK: p38 but not p44/42
mitogen-activated protein kinase is required for nitric oxide
synthase induction mediated by lipopolysaccharide in RAW 264.7
macrophages. Mol Pharmacol. 55:481–488. 1999.PubMed/NCBI
|
|
18
|
Xia Z, Dickens M, Raingeaud J, Davis RJ
and Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases
on apoptosis. Science. 270:1326–1331. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gilmore TD: Introduction to NF-kappaB:
Players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brasier AR: The NF-kappaB regulatory
network. Cardiovasc Toxicol. 6:111–130. 2006. View Article : Google Scholar
|
|
21
|
Perkins ND: Integrating cell-signalling
pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007. View Article : Google Scholar
|
|
22
|
Gilmore TD: The Rel/NF-kappaB signal
transduction pathway: Introduction. Oncogene. 18:6842–6844. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tian B and Brasier AR: Identification of a
nuclear factor kappa B-dependent gene network. Recent Prog Horm
Res. 58:95–130. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shao CJ, Kasai Ryoji, Xu JD and Tanaka O:
Saponins from leaves of Acanthopanax senticosus Harms., Ciwujia:
Structures of Ciwujianosides B, C1, C2,
C3, C4, D1, D2 and E.
Chem Pharm Bull. 36:601–608. 1988. View Article : Google Scholar
|
|
25
|
Li Z: Simultaneous determination of
fifteen triterpenoid saponins in different medicinal parts of
Acanthopanax henryi by HPLC-CAD-ESI-MS. Study on chemical
constituents of Acanthopanax henryi (Oliv.) Harms. Hunan University
of Traditional Chinese Medicine; Changsha: pp. 45–66. 2015, In
Chinese.
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Hou JP and Jin Y: Herbal painkillers:
Relief of lingering arthritic pain and rheumatism. The Healing
Power of Chinese Herbs and Medicinal Recipes. Russo E: Routledge
Taylor & Francis Group; Oxford: pp. 413–416. 2005
|
|
28
|
Zhang XD, Li Z, Liu GZ, Wang X, Kwon OK,
Lee HK, Whang WK and Liu XQ: Quantitative determination of 15
bioactive triterpenoid saponins in different parts of Acanthopanax
henryi by HPLC with charged aerosol detection and confirmation by
LC-ESI-TOF-MS. J Sep Sci. 39:2252–2262. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang W, Li W, Han L, Liu L, Zhang Q,
Zhang S, Nikaido T and Koike K: Biologically active triterpenoid
saponins from Acanthopanax senticosus. J Nat Prod. 69:1577–1581.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Opal SM and DePalo VA: Anti-inflammatory
cytokines. Chest. 117:1162–1172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McInnes IB and Scheett G: Cytokines in the
pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 7:429–442.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aggarwal BB and Natarajan K: Tumor
necrosis factors: Developments during the last decade. Eur Cytokine
Netw. 7:93–124. 1996.PubMed/NCBI
|
|
33
|
Brennan FM and McInnes IB: Ebidence that
cytokines play a role in rheumatoid arthritis. J Clin Invest.
118:3537–3545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jun CD, Choi BM, Kim HM and Chung HT:
Involvement of protein kinase C during taxol-induced activation of
murine peritoneal macrophages. J Immunol. 154:6541–6547.
1995.PubMed/NCBI
|
|
35
|
Green SJ, Mellouk S, Hoffman SL, Meltzer
MS and Nacy CA: Cellular mechanisms of nonspecific immunity to
intracellular infection: Cytokine-induced synthesis of toxic
nitrogen oxides from L-arginine by macrophages and hepatocytes.
Immunol Lett. 25:15–19. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gorczyniski RM and Stanely J: Clinical
Immunology. Landes Bioscience; Austin, TX: 1999
|
|
37
|
Green SJ, Nacy CA, Schreiber RD, Granger
DL, Crawford RM, Meltzer MS and Fortier AH: Neutralization of gamma
interferon and tumor necrosis factor alpha blocks in vivo synthesis
of nitrogen oxides from L-arginine and protection against
Francisella tularensis infection in Mycobacterium bovis BCG-treated
mice. Infect Immun. 61:689–698. 1993.PubMed/NCBI
|
|
38
|
Kamijo R, Gerecitano J, Shapiro D, Green
SJ, Aguet M, Le J and Vilcek J: Generation of nitric oxide and
clearance of interferon-gamma after BCG infection are impaired in
mice that lack the interferon-gamma receptor. J Inflamm. 46:23–31.
1995.PubMed/NCBI
|
|
39
|
Green SJ, Scheller LF, Marletta MA, Seguin
MC, Klotz FW, Slayter M, Nelson BJ and Nacy CA: Nitric oxide:
Cytokine-regulation of nitric oxide in host resistance to
intracellular pathogens. Immunol Lett. 43:87–94. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Koeberle A and Werz O: Microsomal
prostaglandin E2 synthase-1. Anti-inflammatory Drug Discovery.
Levin JI and Laufer S: Royal Society of Chemistry Publishing;
Cambridge: pp. 8–12. 2012
|
|
41
|
Pearson G, Robinson F, Beers Gibson T, Xu
BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein
(MAP) kinase pathways: Regulation and physiological functions.
Endocr Rev. 22:153–183. 2001.PubMed/NCBI
|
|
42
|
Nishida E and Gotoh Y: The MAP kinase
cascade is essential for diverse signal transduction pathways.
Trends Biochem Sci. 18:128–131. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kirkwood KL and Rossa C Jr: The potential
of p38 MAPK inhibitors to modulate periodontal infections. Curr
Drug Metab. 10:55–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kaminska B: MAPK signaling pathways as
molecular targets for anti-inflammatory therapy-from molecular
mechanisms to therapeutic benefits. Biochim Biophys Acta.
1754:253–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Surh YJ, Chun KS, Cha HH, Han SS, Keum YS,
Park KK and Lee SS: Molecular mechanisms underlying chemopreventive
activities of anti-inflammatory phytochemicals: Down-regulation of
COX-2 and iNOS through suppression of NF-kappa B activation. Mutat
Res. 480–481:243–268. 2001. View Article : Google Scholar
|
|
46
|
Makarov SS: NF-kappaB as a therapeutic
target in chronic inflammation: Recent advances. Mol Med Today.
6:441–448. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tian L, Zhou DS, Wang KZ, Zhang W, Shi ZB,
Fan LH and Sun S: Association of toll-like receptor 4 signaling
pathway with steroid-induced femoral head osteonecrosis in rats. J
Huazhong Univ Sci Technolog Med Sci. 34:679–686. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kang OH, Chae HS, Choi JG, Oh YC, Lee YS,
Kim JH, Seung MJ, Jang HJ, Bae KH, Lee JH, et al: Ent-pimara-8(14),
15-dien-19-oic acid isolated from the roots of Aralia cordata
inhibits induction of inflammatory mediators by blocking NF-kappaB
activation and mitogen-activated protein kinase pathways. Eur J
Pharmacol. 601:179–185. 2008. View Article : Google Scholar : PubMed/NCBI
|
